ClinVar Miner

Submissions for variant NM_001148.6(ANK2):c.8927C>G (p.Ser2976Cys)

gnomAD frequency: 0.00002  dbSNP: rs371343942
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000618854 SCV000738134 likely benign Cardiovascular phenotype 2023-04-11 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Labcorp Genetics (formerly Invitae), Labcorp RCV001051685 SCV001215853 uncertain significance Long QT syndrome 2024-10-17 criteria provided, single submitter clinical testing This sequence change replaces serine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 2976 of the ANK2 protein (p.Ser2976Cys). This variant is present in population databases (rs371343942, gnomAD 0.02%). This missense change has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 25351510). ClinVar contains an entry for this variant (Variation ID: 519493). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV001571397 SCV001795865 uncertain significance not provided 2024-04-24 criteria provided, single submitter clinical testing Reported in one individual with hypertrophic cardiomyopathy and one individual with unexplained sudden cardiac death in published literature (PMID: 25351510, 27332903); In silico analysis indicates that this missense variant does not alter protein structure/function; Located in exon 38, which is reported as being expressed in a brain-specific transcript (PMID: 1830053, 18790697, 26109584); This variant is associated with the following publications: (PMID: 27332903, 29057844, 1830053, 18790697, 26109584, 25351510)
Fulgent Genetics, Fulgent Genetics RCV002483724 SCV002775746 uncertain significance Cardiac arrhythmia, ankyrin-B-related 2021-10-05 criteria provided, single submitter clinical testing
KardioGenetik, Herz- und Diabeteszentrum NRW RCV002483724 SCV004363567 uncertain significance Cardiac arrhythmia, ankyrin-B-related 2024-01-29 criteria provided, single submitter clinical testing
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille RCV001252391 SCV001428146 likely benign Intellectual disability 2019-01-01 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.